Candel Therapeutics Inc. (NASDAQ: CADL)
$7.0500
-0.0100 ( -1.40% ) 288.3K
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$7.0500
Previous close
$7.0600
Volume
288.3K
Market cap
$314.00M
Day range
$6.8850 - $7.1850
52 week range
$1.1600 - $14.6000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-k/a | Quarterly Reports | 17 | Apr 25, 2024 |
| 8-k | 8K-related | 13 | Apr 11, 2024 |
| 8-k | 8K-related | 13 | Apr 09, 2024 |
| 8-k | 8K-related | 13 | Apr 04, 2024 |
| 10-k | Annual reports | 90 | Mar 28, 2024 |
| 8-k | 8K-related | 15 | Mar 28, 2024 |
| s-8 | Registration statements | 6 | Mar 28, 2024 |
| 8-k | 8K-related | 14 | Mar 06, 2024 |
| 8-k | 8K-related | 14 | Feb 13, 2024 |
| 424b5 | Other | 2 | Feb 13, 2024 |